ResearcherPhilipps University of MarburgNo recent work listed
Heidi Griesmann
Matched on ORCID iD 0000-0003-0701-2947; OpenAlex author ID A5035140761. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2013: 3 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 7
- Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer. First author DOI 10.1016/j.isci.2023.106841↗
- CUX1 Enhances Pancreatic Cancer Formation by Synergizing with KRAS and Inducing MEK/ERK-Dependent Proliferation. Co-author DOI 10.3390/cancers13102462↗
- Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2015-310049↗
- miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer. Co-author DOI 10.1080/2162402x.2016.1160181↗
- Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions. Co-author DOI 10.1136/gutjnl-2012-302577↗
- WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer. Co-author DOI 10.1593/neo.121312↗
- Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancer. Co-author DOI 10.1593/neo.131660↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Patrick Michl · 7 shared papers, 2013–2023 · strength 0.53
- Paper Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer. DOI 10.1016/j.isci.2023.106841↗
- Paper CUX1 Enhances Pancreatic Cancer Formation by Synergizing with KRAS and Inducing MEK/ERK-Dependent Proliferation. DOI 10.3390/cancers13102462↗
- Paper Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer. DOI 10.1136/gutjnl-2015-310049↗
- Bence Sipos · 4 shared papers, 2013–2021 · strength 0.30
- Paper CUX1 Enhances Pancreatic Cancer Formation by Synergizing with KRAS and Inducing MEK/ERK-Dependent Proliferation. DOI 10.3390/cancers13102462↗
- Paper Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer. DOI 10.1136/gutjnl-2015-310049↗
- Paper miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer. DOI 10.1080/2162402x.2016.1160181↗
- Sebastian Krug · 3 shared papers, 2013–2023 · strength 0.25
- Paper Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer. DOI 10.1016/j.isci.2023.106841↗
- Paper miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer. DOI 10.1080/2162402x.2016.1160181↗
- Paper Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic ca… DOI 10.1593/neo.131660↗
- Jonas Rosendahl · 2 shared papers, 2017–2023 · strength 0.24
- Paper Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer. DOI 10.1016/j.isci.2023.106841↗
- Paper Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer. DOI 10.1136/gutjnl-2015-310049↗
- Thomas Mathias Gress · 5 shared papers, 2013–2017 · strength 0.23
- Paper Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer. DOI 10.1136/gutjnl-2015-310049↗
- Paper miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer. DOI 10.1080/2162402x.2016.1160181↗
- Paper WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer. DOI 10.1593/neo.121312↗
- Tom Kaune · 1 shared paper, 2023 · strength 0.16
- Monika Hämmerle · 1 shared paper, 2023 · strength 0.16
- Iréne Esposito · 1 shared paper, 2021 · strength 0.14
- Nada Milosevic · 2 shared papers, 2013–2017 · strength 0.11
- Malte Buchholz · 3 shared papers, 2013 · strength 0.10
- Paper WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer. DOI 10.1593/neo.121312↗
- Paper Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic ca… DOI 10.1593/neo.131660↗
- Paper Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions. DOI 10.1136/gutjnl-2012-302577↗
- Leonie Mühlberg · 2 shared papers, 2013–2016 · strength 0.09
- Christian P. Pilarsky · 2 shared papers, 2013 · strength 0.07
- Marvin Schober · 1 shared paper, 2016 · strength 0.05
- Victoria E. Shaw · 1 shared paper, 2016 · strength 0.05
- Magdalena Huber · 1 shared paper, 2016 · strength 0.05
- Eithne Costello · 1 shared paper, 2016 · strength 0.05
- Sandra Baumgart · 1 shared paper, 2013 · strength 0.03
- Volker Ellenrieder · 1 shared paper, 2013 · strength 0.03
- Stephan A. Hahn · 1 shared paper, 2013 · strength 0.03
- Volker Fendrich · 1 shared paper, 2013 · strength 0.03
- Albrecht Neeße · 1 shared paper, 2013 · strength 0.03
- David Arthur Tuveson · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.